← brief for 2026-08-10 · Slowing decline
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Key takeaways
This is a new trial that is just starting. It will test a drug called AP306 in adults on dialysis who have too much phosphate in their blood. High phosphate is common in dialysis and can harm the heart and bones. The study checks if the drug is safe and lowers phosphate, and there are no results yet.
Who did this work
Clinical Trials Information